We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ergomed Plc | LSE:ERGO | London | Ordinary Share | GB00BN7ZCY67 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,346.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMERGO
RNS Number : 0779L
Ergomed plc
16 April 2018
Ergomed Plc
("Ergomed" or the "Company")
Directors' Dealing
Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 16 April 2018, Dr Miroslav Reljanovic, founder and Executive Vice-Chairman of the Company, sold 4,000,000 ordinary shares of 1p each in the Company ("Share(s)") at a price of 190p per Share to meet institutional demand.
Following this transaction, Dr Miroslav Reljanovic's holding has reduced to 11,132,237 shares (representing 24.9 per cent. of the Company's issued share capital).
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 Details of the person discharging managerial responsibilities/person closely associated a) Name Dr Miroslav Reljanovic ---------------------------------------- -------------------------------------- 2 Reason for the notification -------------------------------------------------------------------------------- a) Position/status Founder and Executive Vice-Chairman ---------------------------------------- -------------------------------------- b) Initial notification Initial Notification /Amendment ---------------------------------------- -------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor -------------------------------------------------------------------------------- a) Name Ergomed Plc ---------------------------------------- -------------------------------------- b) Legal Entity 213800BVS8I9VMC1AP84 Identifier ---------------------------------------- -------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted -------------------------------------------------------------------------------- a) Description of Ordinary shares of 1 pence each the financial instrument, type of instrument GB00BN7ZCY67 Identification code ---------------------------------------- -------------------------------------- b) Nature of the Sale of shares transaction ---------------------------------------- -------------------------------------- c) Currency GBP ---------------------------------------- -------------------------------------- d) Price(s) and Price(s) Volume(s) volume(s) ---------------------------------------- ----------------- ------------------- 190p 4,000,000 --------------------------------------------- ----------------- ------------------- e) Aggregated information Volume: 4,000,000 - Aggregated Price: 190p volume Aggregated volume: GBP7,600,000 - Price - Aggregated total ---------------------------------------- -------------------------------------- f) Date of the transaction 16 April 2018 ---------------------------------------- -------------------------------------- g) Place of the London Stock Exchange, AIM transaction ---------------------------------------- --------------------------------------
Enquiries:
Ergomed plc Tel: +44 (0) 1483 503205 Stephen Stamp (Chief Executive Officer) Numis Securities Limited Tel: +44 (0) 20 7260 1000 Michael Meade / Freddie Barnfield (Nominated Adviser) James Black (Joint Broker)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHIFMITMBABBJP
(END) Dow Jones Newswires
April 16, 2018 10:55 ET (14:55 GMT)
1 Year Ergomed Chart |
1 Month Ergomed Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions